A Trial of Paclitaxel (Genexol) and Cisplatin Versus Paclitaxel Loaded Polymeric Micelle (Genexol-PM) and Cisplatin in Advanced Non Small Cell Lung Cancer.

Trial Profile

A Trial of Paclitaxel (Genexol) and Cisplatin Versus Paclitaxel Loaded Polymeric Micelle (Genexol-PM) and Cisplatin in Advanced Non Small Cell Lung Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2017

At a glance

  • Drugs Paclitaxel (Primary) ; Cisplatin
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors Samyang Biopharmaceuticals Corporation
  • Most Recent Events

    • 13 May 2013 Status changed from active, no longer recruiting to completed, based on information in a Sorrento Therapeutics and IgDraSol media release.
    • 12 Oct 2010 Primary endpoint results presented at the 35th Congress of the European Society for Medical Oncology
    • 07 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top